PET/CT诊断子宫内膜癌的优势及展望

doi:10.11904/j.issn.1002-3070.2018.02.011

Abstract

Abstract: Endometrial cancer is one of three major gynecological malignancies.When compared with the traditional imaging methods,PET/CT combines the characteristics of anatomy and molecular imaging.In this paper,we describe its advantages in detection of metastatic lymph nodes,monitoring of disease recurrence and prognosis.The complementary effect is compared between PET and CT with MRI.With the development of new tracer and PET/MRI technology,the application of PET/CT is more extensive.

Key words: Endometrial cancer, Recurrence, Metastasis, Prognosis

CLC Number:

R445.5

GONG Wei, Md Tofiz Uddin, LU Peiou, YU Lijuan. Advantages and prospects of PET/CT in the diagnosis of endometrial cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 144-148.

References

1 Kim HJ,Cho A,Yun M,et al.Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer[J].Ann Nucl Med,2016,30(2):104-113.
2 Kakhki VR,Shahriari S,Treglia G,et al.Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients:systematic review and meta-analysis of the literature[J].Int J Gynecol Cancer,2013,23(9):1536-1543.
3 张莉.MRI对子宫内膜癌浸润、淋巴结转移、宫颈间质受累的诊断价值分析[J].中国CT和MRI杂志,2016,14(3):88-90.
4 Antonsen SL,Jensen LN,Loft A,et al.MRI,PET/CT and ultrasound in the preoperative staging of endometrial cancer-a multicenter prospective comparative study[J].Gynecol Oncol,2013,128(2):300-308.
5 Koplay M,Dogan NU,Erdogan H,et al.Diagnostic efficacy of diffusion-weighted MRI for pre-operative assessment of myometrial and cervical invasion and pelvic lymph node metastasis in endometrial carcinoma[J].J Med Imaging Radiat Oncol,2014,58(5):538-546.
6 Simcock B,Narayan K,Drummond E,et al.The role of positron emission tomography/computed tomography in planning radiotherapy in endometrial cancer[J].Int J Gynecol Cancer,2015,25(4):645-649.
7 Amit A,Person O,Keidar Z.FDG PET/CT in monitoring response to treatment in gynecological malignancies[J].Curr Opin Obstet Gynecol,2013,25(1):17-22.
8 宁秋萍,蔡莉,陈秋松,等.女性正常子宫内膜及卵巢对¹⁸F-FDG的生理性摄取特点[J].中国医学影像技术,2011(6):1247-1250.
9 王颖,黄浩,仲勇,等.子宫内膜癌诊治进展及争议焦点[J].医学理论与实践,2016,29(6):732-734.
10 Denschlag D,Ulrich U,Emons G.The diagnosis and treatment of endometrial cancer:progress and controversies[J].Dtsch Arztebl Int,2010,108(34/35):571-577.
11 Antonsen SL,Loft A,Fisker R,et al.SUV_max of ¹⁸FDG PET/CT as a predictor of high-risk endometrial cancer patients[J].Gynecol Oncol,2013,129(2):298-303.
12 Nogami Y,Banno K,Irie H,et al.The efficacy of preoperative positron emission tomography-computed tomography(PET-CT)for detection of lymph node metastasis in cervical and endometrial cancer:clinical and pathological factors influencing it[J].Jpn J Clin Oncol,2015,45(1):26-34.
13 Chang MC,Chen JH,Liang JA,et al.¹⁸F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer:a systematic review and meta-analysis.[J].Eur J Radiol,2012,81(11):3511-3517.
14 Crivellaro C,Signorelli M,Guerra L,et al.Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer:the role of ¹⁸F-FDG PET/CT[J].Gynecol Oncol,2013,130(2):306-311.
15 Kitajima K,Suenaga Y,Ueno Y,et al.Preoperative risk stratification using metabolic parameters of ¹⁸F-FDG PET/CT in patients with endometrial cancer[J].Eur J Nucl Med Mol Imaging,2015,42(8):1268-1275.
16 Fung-Kee-Fung M,Dodge J,Elit L,et al.Follow-up after primary therapy for endometrial cancer:a systematic review[J].Gynecol Oncol,2006,101(3):520-529.
17 Sorbe B,Juresta C,Ahlin C.Natural history of recurrences in endometrial carcinoma[J].Oncol Lett,2014,8(4):1800-1806.
18 Shim SH,Kim DY,Lee DY,et al.Metabolic tumour volume and total lesion glycolysis,measured using preoperative ¹⁸F-FDG PET/CT,predict the recurrence of endometrial cancer[J].BJOG,2014,121(9):1097-1106.
19 Kadkhodayan S,Shahriari S,Treglia G,et al.Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients:systematic review and meta-analysis of the literature[J].Gynecol Oncol,2013,128(2):397-404.
20 Sharma P,Kumar R,Singh H,et al.Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma:comparison with conventional imaging[J].Nucl Med Commun,2012,33(2):185-190.
21 Fotopoulou C,El-Balat A,du Bois A,et al.Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer[J].Arch Gynecol Obstet,2015,292(6):1321-1327.
22 Walentowicz-Sadlecka M,Malkowski B,Walentowicz P,et al.The preoperative maximum standardized uptake value measured by ¹⁸F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients[J].Biomed Res Int,2014,2014:234813.
23 张凤仙,张建,陈素芸,等.¹⁸F-FDG PET/CT显像SUV_max对子宫内膜癌术前浸润及转移的评估价值[J].中华核医学与分子影像杂志,2017,37(2):75-80.
24 Husby JA,Reitan BC,Biermann M,et al.Metabolic tumor volume on ¹⁸F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients[J].J Nucl Med,2015,56(8):1191-1198.
25 Haldorsen IS,Salvesen HB.What is the best preoperative imaging for endometrial cancer?[J].Curr Oncol Rep,2016,18(4):25.
26 Lee HJ,Ahn BC,Hong CM,et al.Preoperative risk stratification using(18)F-FDG PET/CT in women with endometrial cancer[J].Nuklearmedizin,2011,50(5):204-213.
27 Challapalli A.New radiotracers in gynecological cancer:beyond ¹⁸F-FDG[J].Q J Nucl Med Mol Imaging,2016,60(2):139-153.
28 Vercellino LS,Groheux D,Delord M,et al.Hypoxia imaging of uterine cervix carcinoma with ¹⁸F-FETNIM PET[J].Eur J Nucl Med Mol Imaging,2011,38(11):120.
29 Grigsby PW,Malyapa RS,Higashikubo R,et al.Comparison of molecular markers of hypoxia and imaging with 60Cu-ATSM in cancer of the uterine cervix[J].Mol Imaging Biol,2007,9(5):278-283.
30 Tsujikawa T,Yoshida Y,Kiyono Y,et al.Functional oestrogen receptor alpha imaging in endometrial carcinoma using 16alpha-¹⁸F fluoro-17beta-oestradiol PET[J].Eur J Nucl Med Mol Imaging,2011,38(1):37-45.
31 Beiderwellen K,Grueneisen J,Ruhlmann V,et al.[¹⁸F]FDG PET/MRI vs.PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis:initial results[J].Eur J Nucl Med Mol Imaging,2015,42(1):56-65.
32 Shih IL,Yen RF,Chen CA,et al.Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR:correlation with pathological prognostic factors[J].J Magn Reson Imaging,2015,42(6):1723-1732.

[1]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[2]	MENG Hai,DU Guanxiang,ZHU Liling,TANG Qiyun. The expression of WEE1 in gastric cancer and its influence on prognosis of patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 239-243.
[3]	LI Jiaqi,LUAN Jinwei,ZHANG Yu,LI Xianglan. Analysis of clinicopathological features,recurrence and metastasis in 763 triple-negative breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 244-249.
[4]	FENG Yue,XING Linan,WANG Zhao,ZHANG Yunyan. Correlation between NLR and prognosis of concurrent chemoradiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 284-288.
[5]	BAI Xiaobin, HUO Longwei, XIE Wanfu, XU Gaofeng, WANG Maode. Expression of Chk1 in glioblastoma and its association with tumor biological behavior and prognosis survival [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 122-127.
[6]	SHI Xiaokang, DING Youming, WANG Bin, YU Bin, XU Yu. Expression and clinical significance of UBE2T in primary liver cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 128-133.
[7]	LU Jiaoyun, ZHANG Qingyuan. Advances in laboratory markers in the prognosis of diffuse large B-cell lymphoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 183-187.
[8]	ZHAO Fengjuan, WANG Qi, REN Yunhong, WEI Jueling, LI Lequn, ZHAO Xinhua, TANG Juan, YOU Xuemei. Changes of serum CRP and hs-CRP levels in patients with liver cancer and depression and their influence on prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 27-33.
[9]	ZHANG Fengchun, JIANG Ying, LIU Zhaonan, YAN Ningning, CUI Hongquan, XU Yingchun. Prognostic significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in systemic inflammation-related indicators in gastric cancer patients after radical resection [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 34-39.
[10]	MA Jianli, ZHANG Minghui, JI Hongfei, XU Xiangying. Clinical significance of combined detection of PD-L1 protein and CD8⁺TILs in resected lung adenocarcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 40-46.
[11]	YANG Hongbo, SHI Jie, YE Yong, LI Wencheng, DENG Zhaoping. Expression of COL5A2 in bladder cancer tissues and its correlation with clinicopathological features and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 52-56.
[12]	YU Fang, ZHAO Pei. The role and mechanism of TRAP1 in the development of esophageal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 515-519.
[13]	WANG Yalong, LYU Zhangyan, ZHANG Fan, FENG Xiaoshuang, WEI Luopei, LI Xin, WEN Yan, GAO Yushun, XUE Qi, GAO Shugeng, TAN Fengwei. Relationship between human papillomavirus infection and prognosis of lung cancer:A meta-analysis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 520-526.
[14]	TANG Shuli, HE Kuangbang, ZHANG Chunhui, CHENG Jianan, ZHANG Yanqiao. Expression of miR-320a and CYLD in gastric cancer and its relationship with clinicopathological characteristics and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 538-544.
[15]	XIAO Hongwei, CHEN Sheng, WANG Yanliang, SU Xueliang. The prognostic and influence factors analysis of transanal local resection for stage T₁ rectal cancer with the distance from anal margin ≤8 cm [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 545-549.

Advantages and prospects of PET/CT in the diagnosis of endometrial cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments